135 related articles for article (PubMed ID: 23277592)
1. Using patient-reported health status to improve prognostic assessment in patients with acute myeloid leukemia: current challenges and future applications.
Efficace F; Lo-Coco F
Haematologica; 2013 Jan; 98(1):7-9. PubMed ID: 23277592
[No Abstract] [Full Text] [Related]
2. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.
Deschler B; Ihorst G; Platzbecker U; Germing U; März E; de Figuerido M; Fritzsche K; Haas P; Salih HR; Giagounidis A; Selleslag D; Labar B; de Witte T; Wijermans P; Lübbert M
Haematologica; 2013 Feb; 98(2):208-16. PubMed ID: 22875615
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related myeloid neoplasms following treatment with radioiodine.
Schroeder T; Kuendgen A; Kayser S; Kröger N; Braulke F; Platzbecker U; Klärner V; Zohren F; Haase D; Stadler M; Schlenk R; Czibere AG; Bruns I; Fenk R; Gattermann N; Haas R; Kobbe G; Germing U
Haematologica; 2012 Feb; 97(2):206-12. PubMed ID: 21993688
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes in acute myeloid leukemia: Where are we now?
Buckley SA; Kirtane K; Walter RB; Lee SJ; Lyman GH
Blood Rev; 2018 Jan; 32(1):81-87. PubMed ID: 28888621
[TBL] [Abstract][Full Text] [Related]
5. Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis.
Stauder R; Lambert J; Desruol-Allardin S; Savre I; Gaugler L; Stojkov I; Siebert U; Chevrou-Séverac H
Eur J Haematol; 2020 May; 104(5):476-487. PubMed ID: 31985078
[TBL] [Abstract][Full Text] [Related]
6. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
Maynadié M; Girodon F; Manivet-Janoray I; Mounier M; Mugneret F; Bailly F; Favre B; Caillot D; Petrella T; Flesch M; Carli PM
Haematologica; 2011 Jan; 96(1):55-61. PubMed ID: 20971817
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial.
Kantarjian HM; Fenaux P; Sekeres MA; Szer J; Platzbecker U; Kuendgen A; Gaidano G; Wiktor-Jedrzejczak W; Carpenter N; Mehta B; Franklin J; Giagounidis A
Lancet Haematol; 2018 Mar; 5(3):e117-e126. PubMed ID: 29396092
[TBL] [Abstract][Full Text] [Related]
8. Acute leukemia arising after radioiodine treatment for thyroid cancer.
Gilabert M; Prebet T
Haematologica; 2012 Aug; 97(8):e28-9; author reply e30. PubMed ID: 22855847
[No Abstract] [Full Text] [Related]
9. Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.
Inoue Y; Nakamura T; Nakanishi H; Oishi M; Hongo F; Okihara K; Mizutani S; Kuroda J; Ukimura O
Int J Urol; 2018 Jul; 25(7):678-683. PubMed ID: 29752743
[TBL] [Abstract][Full Text] [Related]
10. Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: report from an international workshop.
Karrison T; Archer KJ; Espinosa R; Wen M; Huo D
Genes Chromosomes Cancer; 2002 Apr; 33(4):346-61. PubMed ID: 11921270
[No Abstract] [Full Text] [Related]
11. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease.
Lopez A; Mounier M; Bouvier AM; Carrat F; Maynadié M; Beaugerie L; Peyrin-Biroulet L;
Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1324-9. PubMed ID: 24582568
[TBL] [Abstract][Full Text] [Related]
12. Outcome of acute myeloid leukemia and high-risk myelodysplastic syndrome according to health insurance status.
Al-Ameri A; Anand A; Abdelfatah M; Kanaan Z; Hammonds T; Haller N; Cherry M
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):509-13. PubMed ID: 25108681
[TBL] [Abstract][Full Text] [Related]
13. Risk of Myeloid Neoplasms in Inflammatory Bowel Disease Patients Is Linked to Exposure to Thiopurines and Not With Tumor Necrosis Factor-alpha Inhibitors.
Deepak P; Stobaugh DJ
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1857-8. PubMed ID: 25158928
[No Abstract] [Full Text] [Related]
14. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract][Full Text] [Related]
15. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology of leukemia and MDS among atomic bomb survivors in Hiroshima and Nagasaki suggests how abnormal epigenetic regulation contributes to leukemogenesis].
Inaba T
Rinsho Ketsueki; 2009 Oct; 50(10):1548-52. PubMed ID: 19915365
[No Abstract] [Full Text] [Related]
17. Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan.
Ugai T; Matsuo K; Sawada N; Iwasaki M; Yamaji T; Shimazu T; Goto A; Inoue M; Kanda Y; Tsugane S;
Int J Cancer; 2018 Mar; 142(6):1130-1138. PubMed ID: 29076523
[TBL] [Abstract][Full Text] [Related]
18. Rare occurrence of DNMT3A mutations in myelodysplastic syndromes.
Thol F; Winschel C; Lüdeking A; Yun H; Friesen I; Damm F; Wagner K; Krauter J; Heuser M; Ganser A
Haematologica; 2011 Dec; 96(12):1870-3. PubMed ID: 21880636
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly.
Klepin HD
Clin Geriatr Med; 2016 Feb; 32(1):155-73. PubMed ID: 26614866
[TBL] [Abstract][Full Text] [Related]
20. Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Warren JL; Brown ML
J Natl Cancer Inst; 2007 Jul; 99(13):1050; author reply 1051-2. PubMed ID: 17596580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
